Canada
· Delayed Price · Currency is CAD Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of CAD 823.97 million. The enterprise value is 1.48 billion.
| Market Cap | 823.97M |
| Enterprise Value | 1.48B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Cresco Labs has 347.67 million shares outstanding. The number of shares has increased by 11.58% in one year.
| Shares Outstanding | 347.67M |
| Shares Change (YoY) | +11.58% |
| Shares Change (QoQ) | +0.97% |
| Owned by Insiders (%) | 1.24% |
| Owned by Institutions (%) | 7.43% |
| Float | 318.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.80 |
| PB Ratio | 1.29 |
| P/FCF Ratio | 9.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.23, with an EV/FCF ratio of 17.00.
| EV / Earnings | -6.25 |
| EV / Sales | 1.47 |
| EV / EBITDA | 5.23 |
| EV / EBIT | 9.78 |
| EV / FCF | 17.00 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 182.14.
| Current Ratio | 2.00 |
| Quick Ratio | 1.22 |
| Debt / Equity | 182.14 |
| Debt / EBITDA | 3.31 |
| Debt / FCF | 10.75 |
| Interest Coverage | 1.95 |
Financial Efficiency
Return on equity (ROE) is -35.12% and return on invested capital (ROIC) is 6.08%.
| Return on Equity (ROE) | -35.12% |
| Return on Assets (ROA) | 4.81% |
| Return on Capital (ROIC) | 6.08% |
| Revenue Per Employee | 346,798 |
| Profits Per Employee | -81,393 |
| Employee Count | 2,760 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 3.43 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.58% in the last 52 weeks. The beta is 1.95, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +64.58% |
| 50-Day Moving Average | 2.28 |
| 200-Day Moving Average | 2.48 |
| Relative Strength Index (RSI) | 50.84 |
| Average Volume (20 Days) | 32,087 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of CAD 1.01 billion and -236.04 million in losses. Loss per share was -0.69.
| Revenue | 1.01B |
| Gross Profit | 498.39M |
| Operating Income | 151.00M |
| Pretax Income | -179.79M |
| Net Income | -236.04M |
| EBITDA | 241.07M |
| EBIT | 151.00M |
| Loss Per Share | -0.69 |
Balance Sheet
The company has 153.69 million in cash and 933.62 million in debt, giving a net cash position of -779.92 million or -2.24 per share.
| Cash & Cash Equivalents | 153.69M |
| Total Debt | 933.62M |
| Net Cash | -779.92M |
| Net Cash Per Share | -2.24 |
| Equity (Book Value) | 512.57M |
| Book Value Per Share | 1.84 |
| Working Capital | 186.81M |
Cash Flow
In the last 12 months, operating cash flow was 124.48 million and capital expenditures -37.62 million, giving a free cash flow of 86.86 million.
| Operating Cash Flow | 124.48M |
| Capital Expenditures | -37.62M |
| Free Cash Flow | 86.86M |
| FCF Per Share | 0.25 |
Margins
Gross margin is 49.56%, with operating and profit margins of 15.01% and -23.47%.
| Gross Margin | 49.56% |
| Operating Margin | 15.01% |
| Pretax Margin | -17.88% |
| Profit Margin | -23.47% |
| EBITDA Margin | 23.97% |
| EBIT Margin | 15.01% |
| FCF Margin | 8.64% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.58% |
| Shareholder Yield | -11.58% |
| Earnings Yield | -29.22% |
| FCF Yield | 10.54% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |